131 related articles for article (PubMed ID: 1896091)
1. Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release.
Donati D; Degiannis D; Homer L; Gastaldi L; Raskova J; Raska K
Nephron; 1991; 58(3):268-75. PubMed ID: 1896091
[TBL] [Abstract][Full Text] [Related]
2. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
[TBL] [Abstract][Full Text] [Related]
3. Uremic serum effects on peripheral blood mononuclear cell and purified T lymphocyte responses.
Donati D; Degiannis D; Raskova J; Raska K
Kidney Int; 1992 Sep; 42(3):681-9. PubMed ID: 1405346
[TBL] [Abstract][Full Text] [Related]
4. Production and kinetics of interleukin-1 in hemodialysis. In vivo and in vitro study.
Donati D; Degiannis D; Homer L; Raska K; Raskova J
Am J Nephrol; 1991; 11(6):451-8. PubMed ID: 1819211
[TBL] [Abstract][Full Text] [Related]
5. Immunological studies in uremic and kidney transplanted patients.
Langhoff E
Dan Med Bull; 1989 Apr; 36(2):160-75. PubMed ID: 2651030
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo flow cytometry determination of intracytoplasmic expression of IL-2, IL-6, IFN-gamma, and TNF-alpha in monocytes and T lymphocytes, in chronic hemodialysis patients.
Rostaing L; Peres C; Tkaczuk J; Charlet JP; Bories P; Durand D; Ohayon E; de Préval C; Abbal M
Am J Nephrol; 2000; 20(1):18-26. PubMed ID: 10644863
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of interleukin 2 (IL-2) production and expression of IL-2 receptors by uraemic and normal lymphocytes.
Langhoff E; Hofmann B; Odum N; Ladefoged J; Platz P; Ryder LP; Svejgaard A
Scand J Immunol; 1987 Jan; 25(1):29-36. PubMed ID: 3101170
[TBL] [Abstract][Full Text] [Related]
8. Effects of hemodialysis on activation of lymphocytes: analysis by an in vitro dialysis model.
Donati D; Degiannis D; Combates N; Raskova J; Raska K
J Am Soc Nephrol; 1992 Apr; 2(10):1490-7. PubMed ID: 1600120
[TBL] [Abstract][Full Text] [Related]
9. Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression.
Zaoui P; Green W; Hakim RM
Kidney Int; 1991 May; 39(5):1020-6. PubMed ID: 2067197
[TBL] [Abstract][Full Text] [Related]
10. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.
Descamps-Latscha B; Herbelin A; Nguyen AT; Roux-Lombard P; Zingraff J; Moynot A; Verger C; Dahmane D; de Groote D; Jungers P
J Immunol; 1995 Jan; 154(2):882-92. PubMed ID: 7814891
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 stimulation of blood mononuclear cells from patients with inflammatory bowel disease.
Tvede N; Brynskov J
APMIS; 1991 Aug; 99(8):759-64. PubMed ID: 1859648
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
[TBL] [Abstract][Full Text] [Related]
13. Complement activation in dialysis: effects on cytokines, lymphocyte activation and beta 2 microglobulin.
Gardinali M; Calcagno A; Conciato L; Agostoni A; Rosti A; Cori P; Vozzo N; Moroni A; Anelli A; Zoni U
Int J Artif Organs; 1994 Jun; 17(6):337-44. PubMed ID: 7806419
[TBL] [Abstract][Full Text] [Related]
14. Effect of interleukin-2 and methylprednisolone on in vitro transformation of uremic lymphocytes.
Langhoff E; Ladefoged J; Odum N
Int Arch Allergy Appl Immunol; 1986; 81(1):5-11. PubMed ID: 3488966
[TBL] [Abstract][Full Text] [Related]
15. Modification of some lymphocyte functions in vitro by opioid receptor agonists and antagonist in chronic uremic patients and healthy subjects.
Zbróg Z; Luciak M; Tchórzewski H; Pokoca L
Int J Immunopharmacol; 1991; 13(5):475-83. PubMed ID: 1664419
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
17. The effects of temperature and oleic acid on murine memory and virgin T cell activation: interleukin-2 secretion and interleukin-2 receptor expression.
Wooten RM; Clem LW; Bly JE
Cell Immunol; 1993 Nov; 152(1):35-48. PubMed ID: 8242770
[TBL] [Abstract][Full Text] [Related]
18. T cells activate the tumor necrosis factor-alpha system during hemodialysis, resulting in tachyphylaxis.
van Riemsdijk IC; Baan CC; Loonen EH; Knoop CJ; Navarro Betonico G; Niesters HG; Zietse R; Weimar W
Kidney Int; 2001 Mar; 59(3):883-92. PubMed ID: 11231343
[TBL] [Abstract][Full Text] [Related]
19. Evidence of mononuclear cell activation by hemodialysis.
Donati D; Degiannis D; Combates N; Raskova J; Raska K
ASAIO Trans; 1991; 37(3):M386-7. PubMed ID: 1751200
[TBL] [Abstract][Full Text] [Related]
20. Adoptive immunotherapy with interleukin-2 (IL-2) results in diminished IL-2 production by stimulated peripheral blood lymphocytes.
Kradin R; Kurnick J; Gifford J; Pinto C; Preffer F; Lazarus D
J Clin Immunol; 1989 Sep; 9(5):378-85. PubMed ID: 2533598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
